No Data
No Data
Noil Immune --- For the fiscal year ending December 2024, the in-house drug development business and the joint pipeline will continue to be promoted.
Noil Immune Biotech <4893> announced its financial results for the fiscal year ending December 2024 on the 14th. Business revenue was 0.007 billion yen (compared to 0.316 billion yen in the previous term), operating loss was 1.069 billion yen (compared to a loss of 0.775 billion yen in the previous term), recurring loss was 0.962 billion yen (compared to a loss of 1.127 billion yen in the previous term), and net loss for the year was 0.964 billion yen (compared to a loss of 1.13 billion yen in the previous term). As for the company's business status for the fiscal year, the self-developed drug discovery business based on PRIME technology and the joint pipeline will continue.
List of cloud break stocks (Part 2) [Ichimoku Kinko Hyo - List of cloud break stocks]
○ List of stocks that broke through the clouds Market Code Stock Name Closing Price Leading Span A Leading Span B Main Board <1860> Toda Corporation 951 953 958 <1888> Wakachiku Construction 3685 3720 <1968> Taihei Electric 4980 5075 5085 <1969> Takasago Thermal 5406 6254.25 5572.5 <2108> Sugar Beet 2391 2398.5 2445 <2335> Ki
Stocks that moved or were traded in the first half of the session.
*Takasago International Corporation <4914> 6150 -Significantly revised upward the financial estimates and dividend forecasts. *GMO Internet <4784> 1350 +214 The guidance for this period and expectations for increased dividends continue to have an impact. *PeptiDream <4587> 2343.5 +354 The guidance for increased profits this period is viewed positively. *PKSHA Technology <3993> 4720 +700 The first quarter showed significant profit growth and good progress. *Lion Corporation <4912> 1858.
Sony Group Corp has revised its forecast upwards for March 25, with operating profit of 1 trillion 335 billion yen, up from 1 trillion 310 billion yen.
Sony Group Corp (6758) announced a revision of its Financial Estimates for the fiscal year ending March 2025. Revenue has been revised upwards from 12 trillion 710 billion yen to 13 trillion 200 billion yen, and operating profit from 1 trillion 310 billion yen to 1 trillion 335 billion yen. Entertainment-related segments such as Gaming and music are performing steadily. Additionally, it was announced that a share buyback program with a cap of 50 billion yen has been established, allowing the purchase of up to 30 million shares (0.5% of the total issued shares excluding treasury shares) in the market. 【Positive evaluation】<675
Key points of interest for the PTS on the 13th = Sony Group Corp, Alphapoly, INFORI, Takasago International, ETC.
▽Sony Group Corp <6758.T> announced that the consolidated operating profit for the third quarter cumulative of the fiscal year ending March 2025 (April to December 2024) is 1 trillion 203.5 billion yen, an increase of 23% compared to the same period last year. The full-year performance Financial Estimates have been raised, and a share buyback program has been established. ▽ Alphapoli <9467.T> has raised its consolidated operating profit Financial Estimates for the fiscal year ending March 2025 from 2.51 billion yen to 3.09 billion yen, a 36% increase compared to the previous period. Sales of e-books are strong. The annual Dividends forecast has been increased from 11 yen to 14 yen. ▽ INFORI <9338.T>, for the fiscal year ending January 2025.
Takara Bio Revises Financial Forecasts Amid Global Economic Challenges